Christopher Browne - Tweedy, Browne Co
Holding/activity history for GSK plc (GSK)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 81,785 | 0.36 | Reduce 0.56% | <0.01 | $55.19 | $4,513,714 | SEC |
| 2025 Q4 | 82,243 | 0.33 | $49.04 | $4,033,197 | SEC | ||
| 2025 Q3 | 82,243 | 0.31 | Reduce 5.33% | 0.02 | $43.16 | $3,549,608 | SEC |
| 2025 Q2 | 86,871 | 0.31 | Reduce 4.06% | 0.01 | $38.40 | $3,335,846 | SEC |
| 2025 Q1 | 90,545 | 0.31 | Reduce 3.49% | <0.01 | $38.74 | $3,507,713 | SEC |
| 2024 Q4 | 93,816 | 0.21 | Reduce 13.16% | 0.03 | $33.82 | $3,172,857 | SEC |
| 2024 Q3 | 108,035 | 0.21 | Reduce 1.66% | <0.01 | $40.88 | $4,416,471 | SEC |
| 2024 Q2 | 109,855 | 0.19 | Reduce 10.72% | 0.03 | $38.50 | $4,229,418 | SEC |
| 2024 Q1 | 123,044 | 0.25 | Reduce 1.09% | <0.01 | $42.87 | $5,274,896 | SEC |
| 2023 Q4 | 124,400 | 0.23 | Reduce 4.30% | 0.01 | $37.06 | $4,610,264 | SEC |
| 2023 Q3 | 129,994 | 0.25 | Reduce 3.36% | <0.01 | $36.25 | $4,712,282 | SEC |
| 2023 Q2 | 134,514 | 0.25 | Reduce 0.64% | <0.01 | $35.64 | $4,794,000 | SEC |
| 2023 Q1 | 135,375 | 0.26 | Reduce 2.84% | <0.01 | $35.58 | $4,817,000 | SEC |
| 2022 Q4 | 139,327 | 0.26 | Buy | 0.26 | $35.14 | $4,896,000 | SEC |